A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors

2013 ◽  
Vol 71 (4) ◽  
pp. 1041-1050 ◽  
Author(s):  
Shahneen K. Sandhu ◽  
Kyri Papadopoulos ◽  
Peter C. Fong ◽  
Amita Patnaik ◽  
Christina Messiou ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Human Monoclonal Antibody ◽  
Cc Chemokine ◽  
Chemokine Ligand ◽  
Cc Chemokine Ligand 2 ◽  
Chemokine Ligand 2

Phase I study of CNTO 95, a fully human monoclonal antibody (mAb) to αv integrins, in patients with solid tumors

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3119-3119 ◽  
Author(s):  
G. C. Jayson ◽  
S. Mullamitha ◽  
C. Ton ◽  
J. Valle ◽  
M. Saunders ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Human Monoclonal Antibody

Phase I study of CNTO 95, a fully human monoclonal antibody (mAb) to αv integrins, in patients with solid tumors

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 3113-3113 ◽  
Author(s):  
G. C. Jayson ◽  
S. Mullamitha ◽  
C. Ton ◽  
J. Valle ◽  
A. Jackson ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Human Monoclonal Antibody

Phase I study of CNTO 95, a fully human monoclonal antibody (mAb) to αv integrins, in patients with solid tumors

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3119-3119 ◽  
Author(s):  
G. C. Jayson ◽  
S. Mullamitha ◽  
C. Ton ◽  
J. Valle ◽  
M. Saunders ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Human Monoclonal Antibody
Sign in / Sign up

Export Citation Format

Share Document